Survey Indicates that Veterinarians Believe Generics Are,"The Right Thing To Do"

Portland, ME—March 10, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, announces results of its online survey of veterinarians, in which 100% of veterinarians completing the survey said they believe offering pet parents affordable generic alternatives is the right thing to do and 87% said they believe that prescribing generic alternatives to brand name veterinary medicines may increase customer compliance and trust.

Putney's survey also assessed veterinarian reaction to its recently launched Carprofen Chewable Tablets (generic of Zoetis' Rimadyl® Chewable Tablets). Results support Putney's expectation of deep market penetration—98% of veterinarians surveyed who currently prescribe Rimadyl Chewable Tablets said they are open to prescribing an FDA approved veterinary generic that is therapeutically equivalent to Rimadyl Chewable Tablets and 95% said they would open an account with a new distributor or buy directly from Putney if their current distributor did not carry Putney's Carprofen Chewable Tablets. Zoetis has blocked all national distributors from offering competitive generics, however, Putney's introductory "Buy 1, Get 1 Free" promotion on its Carprofen Chewable Tablets is available through Putney's network of regional distributors and Putney's direct sales.

Jean Hoffman, Putney President and CEO, says veterinarians understand that prescribing FDA approved veterinary generics is not only the right thing to do for pet owners, it is also the right thing to do for their practices. "Our customers tell us that offering

affordable generics of expensive brand pet medicines builds pet owner trust, which leads to customer loyalty and repeat visits," says Hoffman. Putney's analysis of the related carprofen caplet market supports the fact that veterinarians prescribe and sell more of a pet medicine when they offer a generic. After generic carprofen caplets became available, the number of carprofen caplet units sold through veterinarians increased threefold1, indicating more pets were treated when veterinarians had an affordable generic option. Generics now account for over 70% of carprofen caplets dispensed by veterinarians.

Putney launched the online survey on February 10th at Western Veterinary Conference 2015 and continued to receive responses until the survey closed on February 28th.

1 Based

on Putney analysis of market data, January 2015.

 

About Putney

Putney

is a pharmaceutical company committed to providing high quality, cost-effective generic medicines for pets. Putney's reliable supply of affordable drug options empowers veterinarians, allowing them to provide the best possible medicine at the best possible price, and supports pet owners, helping them afford to comply with veterinary recommendations. Putney's ongoing investment in research and development is focused on creating the next generation of generic veterinary products based on inputs from companion animal veterinarians and its industry partners. Learn more at www.putneyvet.com.

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…